Sponsored
  • Asia-Pacific In Vitro Diagnostics Market on Track to Reach $36.02 Billion by 2031
    ‘Asia-Pacific In Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach - Forecast to 2031.’
    According to this latest publication from Meticulous Research®, the Asia-Pacific In Vitro Diagnostics (IVD) market is expected to reach $36.02 billion by 2031 at a CAGR of 7% from 2024 to 2031. The growth of the Asia-Pacific IVD market is attributed to the rising prevalence of chronic and infectious diseases, the growing demand for point-of-care (PoC) and rapid diagnostics, rising awareness regarding early disease diagnosis, rising healthcare expenditures, and increasing funding for research activities. However, stringent technical requirements and regulatory processes for high/moderate-complexity tests and the variance in test results observed in rapid IVD tests restrain the growth of the IVD market. The increasing inclination toward personalized medicine and advancements in genomics and proteomics are expected to create growth opportunities for the players operating in this market. However, the concerns pertaining to false positive results in immunoassays and POC are a major challenge for market growth.
    Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750

    Key Players
    The key players operating in the Asia-Pacific IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Seegene Inc. (South Korea), Illumina, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), QuidelOrtho Corporation (U.S.), and Agilent Technologies Inc. (U.S.).
    Asia-Pacific IVD Market: Future Outlook
    𝐇𝐚𝐯𝐞 𝐚𝐧𝐲 𝐪𝐮𝐞𝐫𝐲 𝐀𝐒𝐊 𝐄𝐗𝐏𝐄𝐑𝐓 :
    https://www.meticulousresearch.com/speak-to-analyst/cp_id=5750
    by Offering
    • Kits & Reagents
    • Instruments
    • Software & Services
    by Technology
    • Molecular Diagnostics
    o Polymerase Chain Reaction (PCR)
    o Hybridization
    o Isothermal Nucleic Acid Amplification Technology
    o DNA Sequencing & Next-generation Sequencing
    o Microarrays
    o Mass Spectrometry
    o Other Molecular Diagnostic Technologies
    • Point of Care (PoC) Diagnostics
    o Lateral Flow Assays/Rapid Tests
    o POC Molecular Diagnostics
    o Other PoC Products
    • Immunoassay/Immunochemistry
    o Enzyme-linked Immunosorbent Assays (ELISA)
    o Radioimmunoassays
    o Western Blotting
    o Enzyme-Linked Immunospot Assays
    o Immunohistochemistry (IHC)
    • Biochemistry/Clinical Chemistry
    o Metabolic Panel
    o Electrolyte Panel
    o Liver Panel
    o Lipid Profile
    o Renal Profile
    o Thyroid Function Panel
    • Whole Blood Glucose Monitoring
    • Microbiology
    • Hematology
    • Coagulation/Hemostasis
    • Urinalysis
    • Other IVD Technologies
    by Application
    • Infectious Diseases
    o COVID-19 Testing
    o Sexually Transmitted Diseases (STD) Testing
    o Healthcare-associated Infections (HAIs)
    o Hepatitis
    o HIV
    o Tropical Diseases
    o Respiratory Infections (Excluding Influenza)
    o Influenza
    o Other Infectious Diseases
    • Oncology
    • Diabetes
    • Cardiology
    • Nephrology
    • Autoimmune Disorders
    • Other Applications
    by Diagnostic Approach
    • Lab Testing
    • OTC/Self-testing
    • Point of Care Testing
    by End User
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Home Healthcare
    • Other End Users
    by Country/Region
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Thailand
    • Singapore
    • Indonesia
    • Rest of Asia-Pacific
    Browse Here:
    https://www.meticulousresearch.com/product/asia-pacific-in-vitro-diagnostics-market-5750
    Key questions answered in the report:
    • Which are the high-growth market segments in terms of offering, technology, application, diagnostic approach, end user, and country
    • What was the historical market for IVD testing in Asia-Pacific
    • What are the market forecasts and estimates for the period 2024–2031
    • What are the major drivers, restraints, challenges, and opportunities in the Asia-Pacific IVD market
    • Who are the major players in the Asia-Pacific IVD market
    Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750

    ContactUs:
    MeticulousResearch®
    Email- sales@meticulousresearch.com
    ContactSales-+1-646-781-8004
    Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

    Asia-Pacific In Vitro Diagnostics Market on Track to Reach $36.02 Billion by 2031 ‘Asia-Pacific In Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach - Forecast to 2031.’ According to this latest publication from Meticulous Research®, the Asia-Pacific In Vitro Diagnostics (IVD) market is expected to reach $36.02 billion by 2031 at a CAGR of 7% from 2024 to 2031. The growth of the Asia-Pacific IVD market is attributed to the rising prevalence of chronic and infectious diseases, the growing demand for point-of-care (PoC) and rapid diagnostics, rising awareness regarding early disease diagnosis, rising healthcare expenditures, and increasing funding for research activities. However, stringent technical requirements and regulatory processes for high/moderate-complexity tests and the variance in test results observed in rapid IVD tests restrain the growth of the IVD market. The increasing inclination toward personalized medicine and advancements in genomics and proteomics are expected to create growth opportunities for the players operating in this market. However, the concerns pertaining to false positive results in immunoassays and POC are a major challenge for market growth. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750 Key Players The key players operating in the Asia-Pacific IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Seegene Inc. (South Korea), Illumina, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), QuidelOrtho Corporation (U.S.), and Agilent Technologies Inc. (U.S.). Asia-Pacific IVD Market: Future Outlook 𝐇𝐚𝐯𝐞 𝐚𝐧𝐲 𝐪𝐮𝐞𝐫𝐲 𝐀𝐒𝐊 𝐄𝐗𝐏𝐄𝐑𝐓 : https://www.meticulousresearch.com/speak-to-analyst/cp_id=5750 by Offering • Kits & Reagents • Instruments • Software & Services by Technology • Molecular Diagnostics o Polymerase Chain Reaction (PCR) o Hybridization o Isothermal Nucleic Acid Amplification Technology o DNA Sequencing & Next-generation Sequencing o Microarrays o Mass Spectrometry o Other Molecular Diagnostic Technologies • Point of Care (PoC) Diagnostics o Lateral Flow Assays/Rapid Tests o POC Molecular Diagnostics o Other PoC Products • Immunoassay/Immunochemistry o Enzyme-linked Immunosorbent Assays (ELISA) o Radioimmunoassays o Western Blotting o Enzyme-Linked Immunospot Assays o Immunohistochemistry (IHC) • Biochemistry/Clinical Chemistry o Metabolic Panel o Electrolyte Panel o Liver Panel o Lipid Profile o Renal Profile o Thyroid Function Panel • Whole Blood Glucose Monitoring • Microbiology • Hematology • Coagulation/Hemostasis • Urinalysis • Other IVD Technologies by Application • Infectious Diseases o COVID-19 Testing o Sexually Transmitted Diseases (STD) Testing o Healthcare-associated Infections (HAIs) o Hepatitis o HIV o Tropical Diseases o Respiratory Infections (Excluding Influenza) o Influenza o Other Infectious Diseases • Oncology • Diabetes • Cardiology • Nephrology • Autoimmune Disorders • Other Applications by Diagnostic Approach • Lab Testing • OTC/Self-testing • Point of Care Testing by End User • Diagnostic Laboratories • Hospitals & Clinics • Home Healthcare • Other End Users by Country/Region • China • Japan • India • Australia • South Korea • Thailand • Singapore • Indonesia • Rest of Asia-Pacific Browse Here: https://www.meticulousresearch.com/product/asia-pacific-in-vitro-diagnostics-market-5750 Key questions answered in the report: • Which are the high-growth market segments in terms of offering, technology, application, diagnostic approach, end user, and country? • What was the historical market for IVD testing in Asia-Pacific? • What are the market forecasts and estimates for the period 2024–2031? • What are the major drivers, restraints, challenges, and opportunities in the Asia-Pacific IVD market? • Who are the major players in the Asia-Pacific IVD market? Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750 ContactUs: MeticulousResearch® Email- sales@meticulousresearch.com ContactSales-+1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
    0 Comments 0 Shares 2139 Views
  • According to a new market research report titled, ‘Africa In Vitro Diagnostics Market by Product & Solution, Technology (Immunoassay, Point of Care, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), End User — Forecast to 2030,’ published by Meticulous Research®, the Africa in vitro diagnostics market is expected to reach $1.49 billion by 2030, at a CAGR of 2.8% from 2023 to 2030.


    Download Free Report Sample Now: https://www.meticulousresearch.com/download-sample-report/cp_id=5415

    High Prevalence of Infectious Diseases Driving the Growth of the Africa IVD Market

    Diagnostic tests are crucial in the medical care of patients with infections. The demand for IVD kits used to diagnose infectious diseases is high in Africa due to the increasing awareness regarding emerging and re-emerging infectious diseases and the adoption of advanced molecular testing and lab-on-chip technology. The burden of diseases such as HIV, tuberculosis, malaria, viral hepatitis, and neglected tropical diseases (NTDs) is large in Africa. For example, according to WHO, in 2020, 25.6 million people were living with HIV in the African Region. The annual number of new HIV infections increased in the Middle East and North Africa (source: UNAIDS data 2021).

    In addition, there is a frequent outbreak of endemic diseases in Africa. For instance, Lassa fever is endemic in Nigeria and continues to be reported nationwide, according to Nigeria Centre for Disease Control and Prevention (NCDC). In January 2022, 981 suspected and 211 confirmed cases of Lassa fever were reported in Nigeria. There were 40 deaths reported among confirmed cases, indicating a case fatality rate of 19%. Thus, the high burden of infectious diseases increases the demand for IVD tests in Africa.

    Africa IVD Market Outlook

    The Africa IVD market is segmented based on Product Category (Reagents, & Kits, Instruments, and Software & Services), Technology (Molecular Diagnostics, Point-of-Care Diagnostics, Immunoassay/Immunochemistry, Biochemistry/Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Microbiology, Coagulation & Hemostasis, and Other IVD Technologies), Application (Infectious Diseases, Oncology, Diabetes, Cardiology, Nephrology, Autoimmune Disorders, and Other Applications), Diagnostic Approach (Lab Testing, Point-of-care Testing, and OTC/Self-testing), and End User (Hospitals & Clinics, Diagnostic Laboratories, Home Healthcare, and Other End Users), and Geography (South Africa, Egypt, Nigeria, Kenya, Algeria, Tanzania, Morocco, Tunisia, and the rest of Africa). The study also evaluates industry competitors and analyzes their market shares.

    Have Any Query Ask To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5415




    Quick Buy – Africa IVD Market - Opportunity Analysis and Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/47708335
    According to a new market research report titled, ‘Africa In Vitro Diagnostics Market by Product & Solution, Technology (Immunoassay, Point of Care, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), End User — Forecast to 2030,’ published by Meticulous Research®, the Africa in vitro diagnostics market is expected to reach $1.49 billion by 2030, at a CAGR of 2.8% from 2023 to 2030. Download Free Report Sample Now: https://www.meticulousresearch.com/download-sample-report/cp_id=5415 High Prevalence of Infectious Diseases Driving the Growth of the Africa IVD Market Diagnostic tests are crucial in the medical care of patients with infections. The demand for IVD kits used to diagnose infectious diseases is high in Africa due to the increasing awareness regarding emerging and re-emerging infectious diseases and the adoption of advanced molecular testing and lab-on-chip technology. The burden of diseases such as HIV, tuberculosis, malaria, viral hepatitis, and neglected tropical diseases (NTDs) is large in Africa. For example, according to WHO, in 2020, 25.6 million people were living with HIV in the African Region. The annual number of new HIV infections increased in the Middle East and North Africa (source: UNAIDS data 2021). In addition, there is a frequent outbreak of endemic diseases in Africa. For instance, Lassa fever is endemic in Nigeria and continues to be reported nationwide, according to Nigeria Centre for Disease Control and Prevention (NCDC). In January 2022, 981 suspected and 211 confirmed cases of Lassa fever were reported in Nigeria. There were 40 deaths reported among confirmed cases, indicating a case fatality rate of 19%. Thus, the high burden of infectious diseases increases the demand for IVD tests in Africa. Africa IVD Market Outlook The Africa IVD market is segmented based on Product Category (Reagents, & Kits, Instruments, and Software & Services), Technology (Molecular Diagnostics, Point-of-Care Diagnostics, Immunoassay/Immunochemistry, Biochemistry/Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Microbiology, Coagulation & Hemostasis, and Other IVD Technologies), Application (Infectious Diseases, Oncology, Diabetes, Cardiology, Nephrology, Autoimmune Disorders, and Other Applications), Diagnostic Approach (Lab Testing, Point-of-care Testing, and OTC/Self-testing), and End User (Hospitals & Clinics, Diagnostic Laboratories, Home Healthcare, and Other End Users), and Geography (South Africa, Egypt, Nigeria, Kenya, Algeria, Tanzania, Morocco, Tunisia, and the rest of Africa). The study also evaluates industry competitors and analyzes their market shares. Have Any Query? Ask To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5415 Quick Buy – Africa IVD Market - Opportunity Analysis and Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/47708335
    0 Comments 0 Shares 2466 Views
  • In-Vitro Diagnostics Market Revenue to Cross USD 107,658.83 Mn by 2027: The Insight Partners
    According to a new market research study titled ‘In-Vitro Diagnostics Market - Global Analysis and Forecasts by Product & Services, Technology, Application, and End User. The global In-Vitro Diagnostics market is expected to reach US$ 107,658.83 Mn in 2027 from US$ 68,608.16 Mn in 2019. The market is estimated to grow with a CAGR of 5.8% from 2020-2027. The report highlights the trends prevalent in the global In-Vitro Diagnostics market and the factors driving the market along with those that act as deterrents to its growth. The market is expected to grow due to rising prevalence of chronic diseases, increasing geriatric population, and rising awareness regarding healthcare. However, lack of healthcare infrastructure and reimbursement policies are likely to pose a negative impact on the market growth.
    Get Sample PDF: https://www.theinsightpartners.com/sample/TIPBT00002657/
    Key Players Influencing the Market
    • F. Hoffmann-la Roche Ltd.
    • Danaher
    • Abbott
    • Siemens AG
    • Sysmex Corporation
    • Thermo Fisher Scientific, Inc.
    • BD
    • Biomérieux SA
    • Bio-Rad Laboratories, INC.
    • Qiagen
    Global In-Vitro Diagnostics market, based on the application is segmented into infectious diseases, diabetes, oncology, cardiology, nephrology, and others. In 2019, the infectious diseases segment held a largest market share of 40.4% of the In-Vitro Diagnostics market, by application. This segment is also expected to dominate the market in 2027 owing to increasing prevalence of the infectious diseases, outbreak of viral infections, and increasing number of tests to prevent prevalence of infectious diseases. Moreover, the diabetes segment is anticipated to witness the significant growth rate of 6.2% during the forecast period, 2020 to 2027 owing to rising government initiatives coupled with increasing prevalence of diabetes.

    Automation deals with the utilization of various intelligent systems with an aim to perform any operation with minimal human intervention. The application of automation in clinical laboratories enables analysts to perform several tests in minimum turnaround time and efforts. Moreover, the automation can serve maximum accuracy in results as well as reduction in variations. Additionally, installation of intelligent software & hardware in clinical analyzers has dramatically improved the overall operating capacity, quality of data processing, and process control in clinical automation. Extensively increasing patient pool is generating massive demand for clinical automation as it offers superior benefits. For instance, in May 2019, Beckman Coulter introduced its new DxA 5000 total laboratory automation solution. The newly launched system is capable of managing high volume samples with significant reduction in procedural time.
    Buy Single User PDF Report@ https://www.theinsightpartners.com/buy/TIPBT00002657/
    Answers that the report acknowledges:
    About Us:
    The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
    Our Most Selling Reports
    Medical Cannabis Market Growth 2022-2028
    Lithium Ion Battery Market Growth 2022-2028
    Metal Coated Fibers Market Growth 2022-2028
    Contact Us:
    533, 5th Floor, Amanora Chambers,
    Amanora Township, East Block,
    Kharadi Road, Hadapsar, Pune-411028
    Call: +1-646-491-9876
    Email: sales@theinsightpartners.com

    In-Vitro Diagnostics Market Revenue to Cross USD 107,658.83 Mn by 2027: The Insight Partners According to a new market research study titled ‘In-Vitro Diagnostics Market - Global Analysis and Forecasts by Product & Services, Technology, Application, and End User. The global In-Vitro Diagnostics market is expected to reach US$ 107,658.83 Mn in 2027 from US$ 68,608.16 Mn in 2019. The market is estimated to grow with a CAGR of 5.8% from 2020-2027. The report highlights the trends prevalent in the global In-Vitro Diagnostics market and the factors driving the market along with those that act as deterrents to its growth. The market is expected to grow due to rising prevalence of chronic diseases, increasing geriatric population, and rising awareness regarding healthcare. However, lack of healthcare infrastructure and reimbursement policies are likely to pose a negative impact on the market growth. Get Sample PDF: https://www.theinsightpartners.com/sample/TIPBT00002657/ Key Players Influencing the Market • F. Hoffmann-la Roche Ltd. • Danaher • Abbott • Siemens AG • Sysmex Corporation • Thermo Fisher Scientific, Inc. • BD • Biomérieux SA • Bio-Rad Laboratories, INC. • Qiagen Global In-Vitro Diagnostics market, based on the application is segmented into infectious diseases, diabetes, oncology, cardiology, nephrology, and others. In 2019, the infectious diseases segment held a largest market share of 40.4% of the In-Vitro Diagnostics market, by application. This segment is also expected to dominate the market in 2027 owing to increasing prevalence of the infectious diseases, outbreak of viral infections, and increasing number of tests to prevent prevalence of infectious diseases. Moreover, the diabetes segment is anticipated to witness the significant growth rate of 6.2% during the forecast period, 2020 to 2027 owing to rising government initiatives coupled with increasing prevalence of diabetes. Automation deals with the utilization of various intelligent systems with an aim to perform any operation with minimal human intervention. The application of automation in clinical laboratories enables analysts to perform several tests in minimum turnaround time and efforts. Moreover, the automation can serve maximum accuracy in results as well as reduction in variations. Additionally, installation of intelligent software & hardware in clinical analyzers has dramatically improved the overall operating capacity, quality of data processing, and process control in clinical automation. Extensively increasing patient pool is generating massive demand for clinical automation as it offers superior benefits. For instance, in May 2019, Beckman Coulter introduced its new DxA 5000 total laboratory automation solution. The newly launched system is capable of managing high volume samples with significant reduction in procedural time. Buy Single User PDF Report@ https://www.theinsightpartners.com/buy/TIPBT00002657/ Answers that the report acknowledges: About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense. Our Most Selling Reports Medical Cannabis Market Growth 2022-2028 Lithium Ion Battery Market Growth 2022-2028 Metal Coated Fibers Market Growth 2022-2028 Contact Us: 533, 5th Floor, Amanora Chambers, Amanora Township, East Block, Kharadi Road, Hadapsar, Pune-411028 Call: +1-646-491-9876 Email: sales@theinsightpartners.com
    WWW.THEINSIGHTPARTNERS.COM
    In-Vitro Diagnostics Market Size, Share, Trends 2021, 2027 : The Insight Partners
    In-Vitro Diagnostics Market size is projected to reach US$ 90,656.80 million by 2027; In 2019, the reagent & kits segment held the largest share of the market.
    0 Comments 0 Shares 336 Views
Sponsored

Instant Money Transfers - Open Free Account

Mobile Money made easy, all currencies

Sponsored